Skip to Main Content

Paper Details

Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes.
medRxiv
1
2022
COVID-19, ED, Metformin, PCOS, Patients, Prediabetes, diabetes, hypothyroidism, levothyroxine, metformin, patients, polycystic ovary syndrome, prediabetes
Author NameAffiliation
Lauren E ChanCollege of Public Health and Human Sciences, Oregon State University
Elena CasiraghiUniversita degli Studi di Milano
Bryan LarawayUniversity of Colorado Anschutz Medical Campus
Ben Coleman
Hannah Blau
Adnin ZamanUniversity of Colorado Anschutz Medical Campus
Nomi L HarrisLawrence Berkeley National Laboratory
Nomi L HarrisLawrence Berkeley National Laboratory
Kenneth J WilkinsNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Michael Gargano
Giorgio ValentiniUniversita degli Studi di Milano
David Sahner
Melissa A HaendelUniversity of Colorado Anschutz Medical Campus
Melissa A HaendelUniversity of Colorado Anschutz Medical Campus
Peter N Robinson
Peter N RobinsonInstitute for Systems Genomics, University of Connecticut
Peter N Robinson
Peter N RobinsonInstitute for Systems Genomics, University of Connecticut
Carolyn T BramanteUniversity of Minnesota
  • 1 - 19

Datasets

Release 1.2